Toxoplasmosis is caused by infection with the protozoan parasite Toxoplasma gondii which has the capacity to infect all warm-blooded animals worldwide. It is estimated that 30-70% of the human population is infected with this parasite, and essentially the entire human population is at risk of infection. A limited number of people develop symptoms, suggesting that host susceptibility and strain disparity can play a role in the variability of clinical symptoms. For instance, in Colombia, where seroprevalence studies show that almost half of the population is infected (47% according a national study), the incidence of symptomatic ocular toxoplasmosis (OT) is of three new episodes per 100,000 inhabitants per year 5 . It is estimated that around 10% of newly infected people develop OT.
INTRODUCTION

RESULTS AND DISCUSSION
We investigated the distribution of the twelve SNPs in 61 Colombian OT-infected patients (cases) and 116 (controls). Genotype distribution of all polymorphisms did not deviate significantly from the Hardy-Weinberg equilibrium. The Association analysis of MAF alleles in cytokines polymorphism in patients with OT and Healthy controls are presented in Table 1 . Most of the SNPs analyses had no significant effect, while the differences proved to be significant for the SNPs rs1800896 and rs2430561 after application of the Bonferroni correction. In our study, the -1082 G allele (P= 1.93E-08; OR=5.27; 95%CI=3.18-8.73; pBONF =3.48E-07) and the +874 A allele (P= 3.37E-05; OR=4.2; 95%CI=2.478-7.12; pBONF =6.07E-04) were higher and significantly represented in OT patients, compared with controls. In the case of the rs1143627 polymorphism, it initially showed a significant effect (OR=1.53 (95% CI 0.98 to 2.37) p= 0.05969), that disappeared when the Bonferroni correction was applied (pBONF =1,00).
Haplotype distribution
We observed five haplotype combinations (TGGCC, TGACC, CGGAC, TAGCC, CGGCT). However, a significant association in the distribution of the haplotype frequencies between cases and healthy controls was not found. The haplotype "GAA" of the IL-1β gene promoter polymorphisms (rs16944, rs1143634, rs1143627) appeared to be significantly associated with susceptibility to ocular toxoplasmosis (p=0.038). The haplotypes "GG and GA" of the IL-10 gene promoter polymorphism (rs1800896, rs1800871), appeared to be significantly associated with OT (p=4.0132E-07 and p=1.1072E-06, respectively. The frequencies are showed in Table 2 .
Our study provides evidence that common genetic variants in Th1 (IL-1, IFN-γ, TNF-α) and Th2 (IL10) Polymorphism in IL-10 gene-promoter (-1082G/A) was significantly more prevalent in OT patients than in controls (P = 1.93E-08; OR=5.27E+03; 95%CI=3.18-8.739; pBONF =3.48E-07). In contrast, the haplotype "AG" of IL-10 gene promoter polymorphism (rs1800896, rs1800871), was present with lower frequency in OT patients [P= 7e-04, OR (95%CI) 0.10 (0.03-0.35)]. The polymorphism (+ 874 A/T) of IFN-γ was associated with OT (P= 3.37E-05; OR=4.2; 95%CI=2.478-7.12; pBONF =6.07E-04). The haplotype "GAG" of IL-1β gene promoter polymorphism (rs1143634, rs1143627, rs16944), appeared to be significantly associated with OT (p=0.0494). The IL-10, IFN-γ and IL-1β polymorphisms influence the development of OT in the Colombian population.
CONCLUSIONS
